Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Procurement pitfalls and hurdles of lab equipment for clinical trials

April 20, 2011 Research and Development clinical trials, medical equipment, mesm, procurement

 Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …
Feature
Thought Leadership

Novavax appoints Stanley Erck chief executive

April 20, 2011 Research and Development appointment, research and development

US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …
Appointment

Warner Chilcott plans to axe 500 jobs in Europe

April 20, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts

Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …
News

Contract research news in brief

April 20, 2011 Research and Development CRO, contract research

Our contract research news round-up features updates from BioClinica, Vyteris, CROMSOURCE, Quintiles, Imperial/D. Anderson and PRA International. Clinical trial management …
News

Circassia raises funds to develop allergy products

April 19, 2011 Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
News
Pfizer

Phase III boost for Pfizer’s oral arthritis drug

April 18, 2011 Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …
News
Genzyme's headquarters

Genzyme MS drug shines in head-to-head trial with Rebif

April 18, 2011 Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …
News

GlaxoSmithKline to drop Alli and other OTC products

April 15, 2011 Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
News
roche

Roche growth stalls after Avastin setback

April 14, 2011 Research and Development, Sales and Marketing Roche

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …
News

Watermeadow continues to grow

April 14, 2011 Research and Development Watermeadow, awards, employees, growth

Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …
Appointment
Lonza, Slough

Lonza expands UK facility, bio business reports growth

April 13, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
News

FDA committee votes in Afinitor’s favour

April 13, 2011 Research and Development, Sales and Marketing

The FDA advisory committee has unanimously backed Novartis’ Afinitor for neuroendocrine tumours of pancreatic origin.  The recommendation comes from the …
News

Free Pharmacovigilance Training Webinar

April 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 Wainwright Associates are offering you the opportunity to attend a FREE thirty minute webinar on “The roles and responsibilities of …
News
Press release

Working Life: Merck Serono’s Wolfgang Wein

April 6, 2011 Research and Development, Sales and Marketing Working Life

Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …
News

Evil big pharma: myth or material?

April 6, 2011 Research and Development, Sales and Marketing Les Rose, industry reputation

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …
Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026